Variables | AOI positive (n = 98) | AOI negative (n = 278) | p value |
---|---|---|---|
Maximal extent, no. (%) | 0.699 | ||
Proctitis, no. (%) | 39 (39.8) | 115 (41.4) | Â |
Left-sided colitis, no. (%) | 29 (29.6) | 84 (30.2) | Â |
Extensive colitis, no. (%) | 30 (30.6) | 79 (28.4) | Â |
Proximal extension, no. (%) | 24 (24.5) | 50 (18.0) | 0.184 |
Mayo endoscopic score at the last endoscopy | 0.516 | ||
0–1, no. (%) | 73 (74.5) | 196 (70.5) |  |
2–3, no. (%) | 25 (25.5) | 82 (29.5) |  |
Histories of medications | |||
High dose 5-ASA, no (%) | 13 (13.3) | 69 (24.8) | 0.016 |
Corticosteroid, no. (%) | 53 (54.1) | 150 (54.0) | 1.000 |
Azathioprine/6-MP, no. (%) | 27 (27.6) | 86 (30.9) | 0.609 |
Anti-TNF agents, no. (%) | 2 (2.0) | 17 (6.1) | 0.177 |
Colectomy, no. (%) | 0 (0.0) | 2 (0.7) | 1.000 |
UC-related hospitalization, no. (%) | 25 (25.5) | 75 (27.0) | 0.894 |
Relapse during follow-up periods, no. (%) | 44 (44.9) | 108 (38.8) | 0.338 |
Follow-up duration, months, median (range) | 56.5 (1-186) | 52.0 (1-245) | 0.285 |